AdipoGen Life Sciences offers a broad range of FNDC4, FNDC5 and Irisin research reagents, including Recombinant Proteins, Antibodies and ELISA Kits.
Extremolytes & BioStab Ready-to-Use Stabilisers of Biological Structures and Macromolecules
Extremolytes such as Ectoine, Hydroxyectoine, Glucosylglycerol and BioStab solutions for biomolecule stabilisation offered by AdipoGen Life Sciences.
NEW Active & Stable Trimeric SARS-CoV-2 Protein – Adipogen
AdipoGen’s SARS-CoV-2 Spike Protein (D614G) (Stable Trimer) (rec.) (His) is a full-length soluble SARS-CoV-2 Spike protein.
New ACE2 (human) ELISA Kit
Adipogen has developed a sensitive and specific colourimetric sandwich ACE2 (human) ELISA Kit.
Antibody Basics: Selecting Antigens – ProSci
When selecting an antigen to use for your project, the considerations required can be overwhelming. ProSci wants your antibody project to run smoothly so your work can be done without interruption. For them to deliver high-performance antibodies, they need the
Bacterial vs. Mammalian Expression Systems – ProSci
Expressing recombinant antibodies can be done in all kinds of systems. Many different cell lines can be used for expressing antibodies, including mammalian cells like HEK293 or CHO, or even yeast, plant or insect cell lines. Each expression system has
Antibody Basics: Recombinant Antibodies – ProSci Inc
The three most common methods to develop recombinant antibodies include display systems, direct B-cell cloning, or the use of pre-existing hybridomas.
Highly Specific SARS-CoV-2 Neutralising Antibodies Detection Kit
AdipoGen Life Sciences has developed a sensitive, specific, and fast SARS-CoV-2 Neutralising Antibodies Detection Kit.
What is an Immunogen? – Prosci
Immunogens and Carrier Proteins What is an immunogen? An immunogen is a specific type of antigen that is able to elicit an immune response. Antibody development is dependent on a humoral immune response mediated by immune cells recognising a molecule
A Summary of ProSci’s Research on HIV – ProSci
ProSci’s roots lie in the research of the Human Immunodeficiency Virus and working to develop a neutralising vaccine against it. Below is an “abstract of abstracts” summarising the research performed over the last several years that has built their business